What's new

Veterinary medicines European public assessment report (EPAR): Cytopoint, lokivetmab, Status: Authorised

Veterinary medicines European public assessment report (EPAR): Cytopoint, lokivetmab, Status: Authorised

Mar 17, 2025 - 17:59
 0
Veterinary medicines European public assessment report (EPAR): Cytopoint, lokivetmab, Status: Authorised
Veterinary medicines European public assessment report (EPAR): Cytopoint, lokivetmab, Status: Authorised
Read More

Tags:

Previous Article

Veterinary medicines European public assessment report (EPAR): Cimalgex, cimicox...

Next Article

WHP Global plans acquisition of Guess

Related Posts

Guideline on assessment and reporting of mechanistic models used in the context of model informed drug development

Guideline on assessment and reporting of mechanistic mo...

Feb 14, 2025  0

Human medicines European public assessment report (EPAR): Bretaris Genuair, aclidinium bromide, Date of authorisation: 20/07/2012, Revision: 20, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 25, 2025  0

Human medicines European public assessment report (EPAR): Beyfortus, nirsevimab, Date of authorisation: 31/10/2022, Revision: 11, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 14, 2025  0